CD44 is also a marker associated with EMT and CSCs in oral cancer and promotes cancer cell aggressiveness by targeting extracellular signal-regulated kinases 1, 2 (ERK1/2) (25). Here, MAPK3 is linked to lip and oral cavity carcinoma.